Overview
Thomas Forlenza is an Oncologist and a Transfusion Medicine provider in Staten Island, New York. Dr. Forlenza is rated as an Experienced provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Pleuropulmonary Blastoma, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, and Breast Cancer.
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Small Lymphocytic Lymphoma (SLL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Trustees Of Columbia University In The City Of New York
Nicole Lamanna is an Oncologist and a Hematologist in New York, New York. Dr. Lamanna is rated as an Elite provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). Her top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Gastrostomy.
Memorial Hematology Lymphoma Group
Andrew Zelenetz is an Oncologist in New York, New York. Dr. Zelenetz is rated as an Elite provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma (MCL), and Diffuse Large B-Cell Lymphoma (DLBCL).
HMH - John Theurer Cancer Center - Hackensack
Andre Goy is an Oncologist and a Hematologist in Hackensack, New Jersey. Dr. Goy is rated as an Elite provider by MediFind in the treatment of Small Lymphocytic Lymphoma (SLL). His top areas of expertise are Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Tissue Biopsy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AgranulocytosisDr. Forlenza isAdvanced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Forlenza isAdvanced. Learn about Aplastic Anemia.
- Breast CancerDr. Forlenza isAdvanced. Learn about Breast Cancer.
- Breast Cancer in MenDr. Forlenza isAdvanced. Learn about Breast Cancer in Men.
- Chronic Familial NeutropeniaDr. Forlenza isAdvanced. Learn about Chronic Familial Neutropenia.
- HemosiderosisDr. Forlenza isAdvanced. Learn about Hemosiderosis.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Forlenza isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Forlenza isExperienced. Learn about Anemia.
- AngiosarcomaDr. Forlenza isExperienced. Learn about Angiosarcoma.
- AstrocytomaDr. Forlenza isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Forlenza isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
- Autoimmune Hemolytic AnemiaDr. Forlenza isExperienced. Learn about Autoimmune Hemolytic Anemia.
